NextWave Pharmaceuticals is a specialty pharmaceutical company with a broad line of prescription pediatric products and over–the–counter products. NextWave develops unique products that address many of the compliance, convenience, dosing and safety issues that consumers face today.
NextWave Pharmaceuticals has an extensive product pipeline of prescription and over–the–counter pediatric products as well as over–the–counter products for adults. NextWave expects to gain FDA approval for several of its pipeline products in the next two years.
Financials
| Date | Type | Amount | Investors | Valuation |
|---|---|---|---|---|
| 02/01/07 | Series B | 40M | Sofinnova Ventures, Vivo Ventures | Unknown |
| 01/01/11 | Series C | 45M | Unknown |
People
Mahendra G. Shah (CEO)
Dennis O’Donnell (EVP, President, OTC Business)
J. George Sarmiento (VP, Business Development)
Stephen Knight (Board member)
Frank Kung (Board Member)
View more details about all 6 people at NextWave Pharmaceuticals
